Expression of cyclooxygenase-2 in prostate carcinoma
β Scribed by Rikio Yoshimura; Hajime Sano; Chikayosi Masuda; Masaki Kawamura; Yasunori Tsubouchi; Jamel Chargui; Norio Yoshimura; Timothy Hla; Seiji Wada
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 406 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Endocrine therapy for prostate cancer aims to reduce the levels of circulating androgen or to inhibit androgen action by blocking the androgen receptor in the prostate, or both. Studies in various animal and human prostate cancer models suggested that there may be a downregulation o
Galectin-1, a member of the beta-galactoside-binding galectin family, is a pleiotropic dimeric protein participating in a variety of normal and pathological processes, including cancer progression. Modulation of the interactions with the basement membrane glycoprotein laminin and induction of apopto